NOVEL FUNCTIONALIZED 5-(PHENOXYMETHYL)-1,3-DIOXANE ANALOGS EXHIBITING CYTOCHROME P450 INHIBITION AND THEIR METHOD OF USE
申请人:CORTENDO AB (PUBL)
公开号:US20160244436A1
公开(公告)日:2016-08-25
Pharmaceutical compositions described in this document comprise 5-(phenoxymethyl)-1,3-dioxane analogs having a disease-modifying action in the treatment of diseases associated with the production of cortisol that include metabolic syndrome, obesity, headache, depression, hypertension, diabetes mellitus, Cushing's Syndrome, pseudo-Cushing syndrome, cognitive impairment, dementia, heart failure, renal failure, psoriasis, glaucoma, cardiovascular disease, cancer, stroke, incidentalomas, or any diseases involving the overproduction of cortisol.
本文中描述的制药组合物包括具有疾病修饰作用的5-(苯氧甲基)-1,3-二噁烷类似物,用于治疗与皮质醇产生有关的疾病,包括代谢综合征、肥胖症、头痛、抑郁症、高血压、糖尿病、库欣综合征、假性库欣综合征、认知障碍、痴呆、心力衰竭、肾衰竭、牛皮癣、青光眼、心血管疾病、癌症、中风、偶发瘤或任何涉及皮质醇过度产生的疾病。